Abstract:Background Probiotics have been shown to improve neurocognitive behaviour in animal models via the gut-brain-axis. This meta-analysis aims to evaluate the evidence in human studies on the potential of probiotics as a treatment for age-related neurodegeneration such as Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). Methods A PRISMA meta-analysis was conducted by screening through MEDLINE, Embase, Scopus, Web of Science and Cochrane library for human studies using equivalent combinations of ‘probiotics’, ‘age-related neurodegeneration’, ‘MCI’ and ‘AD’. Studies with Mini-mental State Examination (MMSE), a test for cognitive function with comparable quantitative outcome were meta-analysed using RStudio. The analysis for overall effect (95% CI) and heterogeneity (I2) was performed by Forest Plots and subgroup analysis. We further assessed whether the results varied with age,%female, BMI, dosage and sample size with weighted meta-regression. Probiotic amelioration of neurodegeneration was also evaluated through biomarker analysis. Results 9 human studies were identified, where 5 studies had quantitative results. Meta-analysis demonstrates that there is a 0.9 mark (0.1 to 1.9) improvement in MMSE scores in human RCTs, though the results are quite heterogeneous (I2 = 94%) (figure 1). Subgroup analysis of MCI and AD models were divergent with a difference of -0.1 (-0.3 to 0.2) versus a 1.7 (0.9 to 2.5) difference in MMSE score between the two groups. Studies also report improvement in other cognitive tests, such as CERAD and RBANS. Meta-regression revealed that the improvement in MMSE scores is age-dependent (p < 0.005) in humans. Biomarker analysis suggests that probiotic supplementation upregulates anti-oxidative (↓MDA) and anti-inflammatory (↓hs-CRP) pathways. Studies also show an improvement in non-neurological symptoms such as in insulin sensitivity (↓HOMA-IR, ↑QUICKI), and lipid profiles (↓TG, VLDL). However, an intervention study reported an increase in kynurenine:tryptophan ratio post probiotic supplementation, suggesting an activation of inflammatory pathways. Conclusions Human study evidence generally shows an association between probiotic supplementation and improved neurocognitive function, although confounded by age and severity of neurodegeneration. Caution should be applied in the use of probiotics as an intervention for cognitive decline.

Effects of Probiotics on Neurodegenerative Disease-Related Symptoms and Systemic Inflammation: A Systematic Review

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis

Probiotics for Neurodegenerative Diseases: A Systemic Review

IDDF2020-ABS-0202 Meta-analysis on the Effect of Probiotics on Neurodegenerative Disorders in Humans Clinical Trials

Modulation of gut microbiome in the treatment of neurodegenerative diseases: a systematic review

Probiotic Supplementation Demonstrates Therapeutic Potential in Treating Gut Dysbiosis and Improving Neurocognitive Function in Age-Related Dementia

Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment — a meta-analysis of randomized controlled trials

The Effect of Probiotic Intervention in Ameliorating the Altered Central Nervous System Functions in Neurological Disorders: A Review

Probiotics as potential therapeutic options for Alzheimer's disease

Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases

The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study

Unveiling the Therapeutic Potential of Modern Probiotics in Addressing Neurodegenerative Disorders: A Comprehensive Exploration, Review and Future Perspectives on Intervention Strategies

Probiotics as potential therapeutic options for Alzheimer’s disease

Probiotics, prebiotics, and synbiotics for the treatment of dementia: Protocol for a systematic review

Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review

Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis

The Effect of Probiotics on Treatments in Patients Affected by Inflammatory Bowel Disease: A Systematic Review

Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights

Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis

Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis

Probiotics Improve Cognitive Impairment by Decreasing Bacteria-Related Pattern Recognition Receptor-Mediated Inflammation in the Gut-Brain Axis of Mice